Abstract:Estrogen is a critical risk factor for cholesterol gallstone disease because women are twice as likely as men to form gallstones. We have identified that the G protein-coupled receptor 30 (GPR30), a new estrogen receptor, is a novel gallstone gene named Lith18 in mice. Supersaturated bile is mainly caused by persistent hepatic cholesterol hypersecretion, which is a prerequisite for gallstone formation. To explore the mechanisms underlying the critical role of GPR30 in promoting hepatic hypersecretion of biliary cholesterol and estrogen-induced gallstones in females, we tested the hypothesis that GPR30 may activate the ATP-binding cassette sterol efflux transporters G5 and G8 (ABCG5/G8), i.e., Lith9, on the canalicular membrane of hepatocytes, leading to a significant increase in hepatic cholesterol output and saturation of bile and enhancing cholelithogenesis. Methods: GPR30 and ABCG8 knockout (KO) mice on a gallstone-resistant AKR genetic background were created, respectively. The biliary and gallstone phenotypes, as well as cholesterol crystallization in gallbladder bile were studied in ovariectomized (OVX) GPR30 KO, ABCG8 KO, and wild-type (WT) mice injected intramuscularly with the potent GPR30-selective agonist G-1 at 0 or 1 μg/day and fed a lithogenic diet for 8 wk. Results: Compared to that in OVX WT mice receiving no G-1, hepatic expression of Abcg5/g8 is significantly increased by G-1 treatment in OVX WT, but not GPR30 or ABCG8 KO, mice fed the lithogenic diet. Moreover, no changes are found in hepatic expression of Abcb4 or Abcb11 for biliary phospholipid and bile acid secretion in these OVX mice treated with G-1 for 8 wk, suggesting that GPR30 activated by G-1 could promote biliary cholesterol hypersecretion by stimulating hepatic expression of Abcg5/G8 in mice. Feeding the lithogenic diet for 8 wk induces gallstone formation in 10% of OVX WT mice receiving no G-1. By contrast, G-1 treatment drastically increases gallstone prevalence to 80% in OVX WT mice. Many solid cholesterol monohydrate crystals embedded within mucin gels are observed in the remaining (20%) mice. However, no gallstones are found in OVX GPR30 KO or ABCG8 KO mice even treated with G-1 and fed the lithogenic diet for 8 wk. Moreover, gallbladder bile is unsaturated with cholesterol in two groups of KO mice. These results show that activation of GPR30 by G-1 enhances susceptibility to gallstone formation by stimulating hepatic Abcg5/g8 expression for promoting hepatic cholesterol hypersecretion in female mice. Conclusions: This study provides direct evidence for the first time that the interaction of GPR30 and ABCG5/G8, i.e., two Lith genes ( Lith9 and Lith18), exerts a synergistic lithogenic effect on promoting hepatic hypersecretion of biliary cholesterol, thereby leading to supersaturated bile and increased prevalence of cholesterol gallstone formation in female mice. NIH R01 DK126369 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice

Expression and Its Significance of Caveolin–1 in Liver and Gallbladder of Gallstone Mice Model

Differences Between Hepatic and Biliary Lipid Metabolism and Secretion in Genetically Gallstone-Susceptible and Gallstone-Resistant Mice

Effect of Hepatic NPC1L1 on Cholesterol Gallstone Disease and Its Mechanism

Effect of baicalin on immune hepatic injury induced by BCG plus LPS in mice

Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.

Characteristics of Mrna Levels of Hepatic Cholesterol Metabolism Regulatory Enzymes in Genetically Gallstone-Susceptible and Resistant Mice

Inhibiting miRNA-146a suppresses mouse gallstone formation by regulating LXR/megalin/cubilin-media cholesterol absorption

Characteristics of Mrna Levels of Hepatic Key Enzymes in Cholesterol Metabolism of Genetically Gallstone-Susceptible Mice.

Baicalin Ameliorates Experimental Liver Cholestasis in Mice by Modulation of Oxidative Stress, Inflammation, and NRF2 Transcription Factor.

Association of Caveolin-3 and Cholecystokinin A Receptor with Cholesterol Gallstone Disease in Mice

Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet

Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation

Aqueous Extract of Lysimachia christinae Hance Prevents Cholesterol Gallstone in Mice by Affecting the Intestinal Microflora

Two gallstone (Lith) genes, Lith9 and Lith18, produces a synergistic effect in enhancing cholelithogenesis by promoting hepatic secretion of biliary cholesterol in female mice

Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway

Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota

Baicalin attenuated oxidative stress and inflammation in ethylene glycol-induced urolithiasis in adult male SD rats

Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models

Changes and Correlations of the Intestinal Flora and Liver Metabolite Profiles in Mice With Gallstones